GenScript LNP Formulation Services: Advanced Delivery Solutions for Therapeutic Research
GenScript provides lipid nanoparticle (LNP) formulation services for efficient delivery of nucleic acids and other therapeutic payloads across a wide range of research applications, including gene editing, vaccines, immunotherapy, and cell engineering. Leveraging expertise in payload synthesis and LNP formulation, GenScript supports the development of customized delivery solutions, including advanced targeted and novel LNP sys…
Receive your quote directly from the manufacturer.
GenScript offers lipid nanoparticle (LNP) formulation services to support efficient delivery of multiple payloads for both in vitro and in vivo research applications. Backed by extensive expertise in payload synthesis and nanoparticle formulation, GenScript provides customized LNP solutions designed to improve payload stability, cellular uptake, and delivery performance for advanced therapeutic research.
The GenScript LNP platform supports encapsulation of multiple payload types, including mRNA, circRNA, saRNA, siRNA, plasmid DNA, and gene editing components. Available services include payload encapsulation, formulation development or optimization, and analytical characterization to support applications such as vaccines, gene editing, immunotherapy, cell engineering, and RNA therapeutic research.
In addition to general LNP formulations, GenScript also offers advanced delivery platforms including targeted LNP systems and novel LNP formulations. The targeted LNP platform is designed to enable enhanced tissue and cell-specific delivery. GenScript novel LNP formulations feature unique lipid compositions developed to achieve strong in vitro and in vivo performance comparable to or exceeding benchmark LNP systems.
Combining expertise in payload preparation, LNP formulation, characterization, and analytical testing, GenScript provides end-to-end support to help researchers streamline delivery development and accelerate translational research programs.
